RSSL - ETF AI Analysis
Top Page
Global X Russell 2000 ETF (RSSL)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, suggesting its small-cap focus has recently worked in investors’ favor.
Strong-Performing Top Holdings
Many of the largest positions, especially in health care and technology, have shown strong performance, helping lift the overall fund.
Low Expense Ratio
The fund’s relatively low fee means more of the ETF’s returns stay in investors’ pockets instead of going to costs.
Negative Factors
High U.S. Concentration
With almost all assets in U.S. stocks, the fund offers limited geographic diversification and is heavily tied to the U.S. economy.
Small-Cap Volatility
Because it tracks smaller companies, the ETF can be more sensitive to market swings and economic uncertainty than large-cap funds.
Recent Short-Term Weakness
The fund has shown weak performance over the past month, which may signal near-term volatility even though longer-term results have been stronger.
RSSL vs. SPDR S&P 500 ETF (SPY)
AUM1.43B
RegionNorth America
Expense Ratio0.08%
Beta1.06
IssuerGlobal X
Inception DateJun 05, 2024
Dividend Yield1.29%
Asset ClassEquity
Index TrackedRussell 2000 RIC Capped Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,835
30 Day Avg. Volume14,252
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
148.33Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1971
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RSSL Summary
The Global X Russell 2000 ETF (RSSL) is a fund that follows the Russell 2000 Index, which is made up of many smaller U.S. companies across sectors like health care, financials, and technology. It gives you broad exposure to small-cap stocks, including names like Moog and JFrog, in a single investment. Someone might consider RSSL to add diversification and potential long-term growth from smaller, fast-growing businesses that aren’t as common in large-cap funds. A key risk is that small-cap stocks can be more volatile than larger companies, so the ETF’s price can move up and down more sharply with the market.
How much will it cost me?The Global X Russell 2000 ETF (RSSL) has an expense ratio of 0.08%, which means you’ll pay $0.80 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks the Russell 2000 Index, keeping costs down compared to actively managed funds.
What would affect this ETF?The Global X Russell 2000 ETF could benefit from economic growth and innovation in small-cap sectors like technology and healthcare, which are heavily represented in its holdings. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact smaller companies that often rely on borrowing and are more sensitive to market conditions. Regulatory changes or sector-specific disruptions could also influence the performance of key industries within the ETF.
RSSL Top 10 Holdings
RSSL is riding a wave of U.S. small-cap health care and tech names, with high‑octane stocks like 10x Genomics and Twist Bioscience doing much of the heavy lifting thanks to their rising momentum. On the flip side, software player JFrog and restaurant operator Brinker International have been more mixed lately, occasionally throwing sand in the gears. Financials such as UMB Financial are steady but not spectacular, helping balance out the more volatile biotech and crypto‑linked Hut 8. Overall, the fund is a U.S.-centric small-cap story tilted toward innovative, higher-risk growth sectors.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Twist Bioscience | 0.40% | $5.84M | $12.04B | 565.18% | 43 Neutral | |
| Moog | 0.36% | $5.25M | $12.34B | 93.63% | 73 Outperform | |
| Hut 8 | 0.35% | $5.02M | $11.93B | 171.15% | ― | |
| JFrog | 0.34% | $4.93M | $11.00B | 79.49% | 73 Outperform | |
| UMB Financial | 0.33% | $4.78M | $10.32B | 12.60% | 77 Outperform | |
| 10x Genomics | 0.33% | $4.72M | $11.17B | 680.42% | 60 Neutral | |
| ViaSat | 0.31% | $4.55M | $10.06B | 152.20% | 56 Neutral | |
| BrightSpring Health Services, Inc. | 0.31% | $4.51M | $11.20B | 101.00% | 67 Neutral | |
| Krystal Biotech | 0.30% | $4.32M | $10.24B | 90.71% | 80 Outperform | |
| Brinker International | 0.30% | $4.31M | $8.65B | 52.25% | 70 Neutral |
RSSL Technical Analysis
Negative
―
Price Trends
114.84
Negative
114.26
Negative
107.87
Positive
Market Momentum
-1.56
Positive
32.50
Neutral
10.13
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RSSL, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 112.37, equal to the 50-day MA of 114.84, and equal to the 200-day MA of 107.87, indicating a neutral trend. The MACD of -1.56 indicates Positive momentum. The RSI at 32.50 is Neutral, neither overbought nor oversold. The STOCH value of 10.13 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RSSL.
RSSL Peer Comparison
Comparison Results
Performance Comparison
RSSL
Global X Russell 2000 ETF
109.38
14.83
15.68%
FNDA
Schwab Fundamental US Small Co. Index ETF
―
―
―
FESM
Fidelity Enhanced Small Cap ETF
―
―
―
SMLF
iShares MSCI USA Small-Cap Multifactor ETF
―
―
―
VIOO
Vanguard S&P Small-Cap 600 ETF
―
―
―
CALF
Pacer US Small Cap Cash Cows 100 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents